diabetic foot
Conditions
Interventions
Treatment group:xiaoduyuji plaster
Sponsors
North China University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) diabetes foot (limb gangrene) examination method and diagnostic criteria in line with the American Diabetes Association Diabetes Prevention guideline (2010 Edition) are in line with diagnostic criteria. (2) 40 ~ 90 years old; (3) the duration of diabetes mellitus was 5~20 years, and the duration of ulcer (gangrene) was 1~10 years. (4) Wagner classification I ~ III (grade I: there are open lesions on the skin of the extremities. Blisters, blood bubbles, corns, or frostbite, scald are superficial ulcers of the skin caused by other skin operations, but the lesions have not yet affected the deep tissue. Grade II: infected lesions to invade the deep muscle tissue. There are often cellulitis, multiple purulent foci, sinus formation or infection, which expand along the muscle space, resulting in penetrating ulcers on the dorsum of the foot, with more purulent secretions, but the tendons and ligaments have not been damaged. Grade III: muscle Destruction of tendon and ligament tissue, fusion of cellulitis, formation of large purulent cavity, increase of purulent secretion and necrotic tissue, but bone destruction is not obvious); (5) All treatment measures and treatments were informed to patients and their families, and informed consent was signed.
Exclusion criteria
Exclusion criteria: (1) Does not meet the above diagnostic and inclusion criteria; (2) If the limb is completely necrotic after admission, it needs amputation or cannot be treated according to the regulations. (3) Combined with cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system diseases, and mental diseases And patients with malignant tumors; (4) Patients with mental disorders or serious psychological disorders; (5) Patients who had taken painkillers and sedatives within one week before treatment; (6) Patients who are participating in other clinical trials. Note: any one of the above shall be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Healing rate of skin ulcer;Oxidative stress index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Apoptosis and proliferation; | — |
Countries
china
Contacts
Public ContactLIQI
Outcome results
None listed